AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: SYMPROIC (BioDelivery Sciences International, Inc.) (symproic.com)
A high-substance, low-fluff pharmaceutical site that prioritizes regulatory compliance and patient safety over marketing hyperbole. It provides exactly what a prescription drug site should: clear indications, verifiable chemical data, and transparent financial assistance. The minor BS detected is purely a result of repetitive benefit-messaging required for brand recall.
To achieve a minimal BS score, include direct outbound links to the peer-reviewed clinical trial results on ClinicalTrials.gov within the ‘How SYMPROIC works’ sections. Add Person schema for the Chief Medical Officer or lead researchers to bridge the anonymity gap. Ensure the footnote markers (*, †) used in H2 headings link directly to the study data in the footer to satisfy proof path requirements. Finally, reduce the repetition of the ‘✓ More frequently’ H2/H3 block to only relevant pages to improve information density.
Information density is exceptionally high due to the mandatory regulatory text. The body substance ratio is strong, citing specific ingredients (D-mannitol, croscarmellose sodium) and technical dosage instructions. However, it loses points in Information Density for repetitive benefit-driven headings like ‘✓ More frequently’ and ‘✓ More completely’ which appear on almost every page without adding new technical depth. The specificity is anchored by clinical metrics, such as the ‘40%-60%’ OIC prevalence rate and the ‘4-week’ efficacy threshold.
When multiple URL variants exist, AI generates multiple embeddings of the same page. Run a Canonical Identity Stability Audit to see whether your site resolves into a single authoritative version.
There is zero semantic drift across the analyzed pages. The homepage H1 ‘Don’t stop for constipation’ is consistently supported by the sub-pages which provide the technical ‘What is OIC’ data and the financial ‘Savings Program’ details. The transition from the consumer-facing hero section to the clinical ‘Medication Guide’ on the sub-pages is seamless and logically maintains the same target audience (adults with chronic non-cancer pain).
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
The site avoids common trust theatre traps like unverified reviews or fake award badges; the review_count is 0 across all pages. Trust is established through regulatory transparency rather than social proof, linking to dailymed.nlm.nih.gov for full prescribing information. It receives a minor penalty for bold performance claims like ‘SYMPROIC may help you go’ having missing direct citations to the primary clinical studies in the text crawl, although footnotes are implied.
Proof density is high for the industry, emphasizing safety warnings and side effect profiles as much as benefits. The ratio of verifiable technical facts (ingredients, storage temperatures, FDA reporting lines) to vague assertions is roughly 5:1. The presence of ICD-10 codes in the schema acts as a high-density proof point that standard consumer health sites typically lack.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The fingerprint is low as the content is tied to a specific patented molecule (naldemedine). It matches a few industry clichés like ‘dedicated to making its medications accessible,’ but these are standard for pharmaceutical access programs. The use of ‘Eligibility Requirements’ and ‘Terms and Conditions’ headings are boilerplate but functionally necessary for the savings program, resulting in a minimal commodity score.
The authority is verified through high-quality JSON-LD schema containing ICD-10 codes (T40.2X5) and specific drug metadata. A minor gap exists as no specific key opinion leaders (KOLs) or medical directors are named in Person schema to personally vouch for the efficacy, relying instead on the organizational authority of BioDelivery Sciences International. The technical implementation is clean with a clear heading hierarchy and valid MedicalCondition schema.
The marketing claims (going more frequently/completely) are directly supported by the medication’s indicated use and clinical description. There is no disconnect between the ‘Save on SYMPROIC’ promise and the detailed ‘Eligibility Requirements’ provided on the savings page. The site explicitly defines its limitations, such as the exclusion of active cancer pain, which reduces the BS score by demonstrating regulatory compliance over marketing hype.
Medical Devices, Pharma & Biotech BS: SYMPROIC (BioDelivery Sciences International, Inc.) (symproic.com)
The website perfectly aligns with the Medical Pharma & Biotech category. The presence of a Medication Guide, Safety Information (ISI), and detailed pharmacological data like naldemedine tosylate confirms its status as a regulated pharmaceutical product site.
When links fail to express hierarchy, the model cannot form clusters or identify primary entities. Examine the Internal Linking Technical Guide and understand how structural signals—not navigation—define your semantic map.
“The score of 14 is driven primarily by concept repetition (5 points) and minor penalties for missing named experts and direct study links in the crawl. The site excels in semantic coherence and technical identity, resulting in zero penalties for messaging drift or technical implementation. It represents a baseline for high-substance medical communication.”